Group 2 Pulmonary Hypertension Workup: Approach Considerations, Laboratory Studies, Electrocardiography
Integrin α5β1 Is Target For Pulmonary Arterial Hypertension
Cardiovascular
Researchers from Morphic Therapeutic Inc. And affiliated organizations published data from a study that aimed to assess the potential of using arginylglycylaspartic acid (RGD) integrins for the treatment of cardiovascular diseases, such as pulmonary arterial hypertension (PAH).
BioWorld Science CardiovascularMacrophages More Inflammatory In Males With PAH Than Females
Males with pulmonary arterial hypertension (PAH) have more proinflammatory macrophages — a type of immune cell — in the lungs than do females with the disease, a study suggests.
Researchers identified 56 genes showing differing activity in macrophages taken from men and women with PAH, with this altered activity mainly taking place in a pathway thought to be involved in cell proliferation.
Lowering the expression (activity) of one of these genes, RPL39, reduced PAH-related changes in male and female rats, attenuating the sex differences.
"Our study provides the first evidence that macrophages play an essential role in the sex differences of PAH," the researchers wrote, adding that targeting these immune cells may offer a new approach in treating PAH.
M1 macrophages amplify inflammation, while M2 macrophages dampen itThe study, "RPL39 Was Associated With Sex Differences in Pulmonary Arterial Hypertension," was published in the Canadian Respiratory Journal.
PAH is characterized by high blood pressures in the pulmonary arteries, vessels that transport blood through the lungs. The disease is marked by vascular remodeling — structural changes that narrow the blood vessels and obstruct blood flow, which leads to PAH symptoms like shortness of breath.
Vascular remodeling is driven, in part, by the infiltration of macrophages in the lungs. In PAH and other pulmonary diseases, studies have shown an imbalance between M1 macrophages, which amplify inflammation by secreting proinflammatory molecules, and anti-inflammatory M2 macrophages.
Female sex is one of the strongest known risk factors for PAH. But survival can be poorer in men with this disease.
"PAH patients exhibit significant sex differences in disease susceptibility, hemodynamic [vessel blood flow] characteristics, right ventricular function, drug treatment response, and survival rate," the scientists wrote.
Researchers in China used two datasets to examine sex differences in lung samples from PAH patients. Comparing three lung samples from females to the same number of samples from males, they found the ratio of macrophages to be about seven times higher in males.
Males also had a significantly higher proportion of proinflammatory M1 macrophages than did females (64.1% vs. 8.2%).
"The increased M1 macrophages in male PAH samples may be associated with more severe disease severity and worse prognosis," the researchers wrote.
Gene activity in inflammatory macrophages could affect cell proliferationGenetic analysis of the macrophages from patients' lungs found the activity of 56 genes to differ between males and females. Specifically, genes in M1 macrophages that differed between the sexes mainly were involved in the ribosome pathway.
Ribosomes are cellular structures responsible for making proteins. Ribosome signaling is involved in processes by which cells proliferate, or grow and divide to create new cells.
"Ribosome signaling pathways have been reported to be involved in cell proliferation, suggesting that inhibition of this pathway could reduce the difference in the ratio of male and female macrophages, thereby attenuating the sex differences in PAH," the researchers wrote.
Investigators then focused on one macrophage gene involved in the ribosome signaling pathway, RPL39. Reducing the expression of RPL39 in a rat model of PAH limited macrophage proliferation in both male and female rats.
In rats of both sexes, RPL39 knockdown (lowered activity) also significantly reduced mean pulmonary artery pressure and pulmonary vascular resistance — a measure of internal resistance to blood flow within the lung's blood vessels — and improved measures of heart function, such as stroke volume (the amount of blood ejected from the ventricle with each contraction).
Likewise, other measures showed that RPL39 knockdown lessened the sex differences in PAH, with changes in males that included a significantly lesser enlargement of the heart's right ventricle (which pumps blood to the lungs) and increased cardiac output (the amount of blood the heart pumps in one minute).
"In summary, our study highlights the essential role of macrophages in the sex differences of PAH. The findings suggest that targeting macrophages may be a potential therapeutic strategy for the treatment of PAH," the researchers wrote.
Hypertension News
Feb. 12, 2025 — South Asian adults in the United Kingdom may face high blood pressure-related heart risks earlier in life, while East Asian adults see risks rise in later years, according to a new ...
Aug. 14, 2024 — People 60 and older with untreated high blood pressure may have an increased risk of Alzheimer's disease compared to both people who have been or are being treated for high blood pressure as ...
Aug. 6, 2024 — Doctors recommend making fruits and vegetables a foundational part of the treatment of patients with hypertension. Diets high in fruits and vegetables are found to lower blood pressure, reduce ...
Aug. 1, 2024 — High blood pressure affects about 45% of U.S. Adults. In the 1970s, only about 50% of patients were aware of their hypertension. Today, 54% are aware of their high blood pressure, 40% are actively ...
Aug. 1, 2024 — Researchers have discovered a link between high blood pressure and tellurium, a contaminant found in various plant-based foods. The study highlights the importance of closely and consistently ...
July 31, 2024 — Having high blood pressure, specifically high diastolic blood pressure, was linked to a slightly higher odds of ever having migraine in female participants, according to a new study. Diastolic ...
July 23, 2024 — Nearly 40 million adults in the U.S. Have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However, the machines tend to be ...
July 23, 2024 — Years of high systolic blood pressure are linked to a greater risk for the two most common types of stroke. The results suggest that early diagnosis and sustained control of high blood pressure over ...
July 19, 2024 — When it comes to community hypertension interventions, a new study found that pharmacists and community health workers had the best success in lowering blood pressure. These findings support the idea ...
July 15, 2024 — According to a new study, both 30-year risk for cardiovascular disease in addition to 10-year risk may be considered in making decisions about when to initiate high blood pressure ...
June 26, 2024 — A study evaluated a cuffless monitor that uses optical sensors to record blood pressure continually and efficiently, without disruption to the ...
June 17, 2024 — The number of individuals in the U.S. Who had chronic hypertension or chronic high blood pressure during pregnancy doubled between 2008 and ...
June 6, 2024 — People with high blood pressure have a higher risk of cognitive impairment, including dementia, but a new study suggests that engaging in vigorous physical activity more than once a week can lower ...
June 5, 2024 — Adolescents with elevated blood pressure and arterial stiffness may experience poorer cognitive functions, according to a recent study. Young people with higher blood pressure performed worse, ...
May 15, 2024 — New research finds a link between common medications and life-threatening ...
May 2, 2024 — Blood vessels in the lungs aren't like the others in the body. This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading ...
Apr. 30, 2024 — Researchers have discovered over a hundred new regions of the human genome, also known as genomic loci, that appear to influence a person's blood pressure. In total, over 2,000 independent ...
Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study. An early phase ...
Apr. 11, 2024 — Health researchers identify patients at risk for preventable death in the year after ...
Mar. 27, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over time, according to a new ...
Comments
Post a Comment